Ratings CareNet, Inc.

Equities

2150

JP3277550004

Market Closed - Japan Exchange Other stock markets 07:00:00 10/05/2024 BST			5-day change	1st Jan Change
572 ^JPY	+0.70%		+2.69%	-47.86%

02-16	CareNet's Profit Down 18% in Fiscal 2023	MT
02-15	CareNet, Inc. Announces Dividend for the year ended December 31, 2023, Payable on March 27, 2024	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

The group's high margin levels account for strong profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last few months, analysts have been revising downwards their earnings forecast.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
CARENET, INC.	-47.86%	164M	-
TENCENT HOLDINGS LIMITED	+26.36%	441B	B
NETFLIX, INC.	+25.47%	263B	D+
UBER TECHNOLOGIES, INC.	+8.80%	140B	A-
AIRBNB, INC.	+7.48%	92.89B	C-
PROSUS N.V.	+25.85%	90.53B	B+
SPOTIFY TECHNOLOGY S.A.	+56.78%	58.64B	B-
DOORDASH, INC.	+16.13%	46.96B	C+
COSTAR GROUP, INC.	+2.85%	36.7B	B
NASPERS LIMITED	+20.84%	36.11B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes